Page 27 - ITPS-5-2

21 INNOSC Theranostics and Pharmacological Sciences, 2022, Vol. 5, No. 2 Govender and Hodkinson
Town, approved the study (HREC reference Indirect Immunofluorescence (IIF) Versus Antigen-specific
number 443/2018). [8] Immunoassays. Ann. Rheum. Dis., 2017, 76, 647–653.
Damoiseaux, J. ANCA Testing in Clinical Practice: From
Implementation to Quality Control and Harmonization. Front.
Consent for Publication Immunol., 2021, 12, 656796.
[9] Robinson, P.C.; Steele, R.H. Appropriateness of Antineutrophil
Not applicable. Cytoplasmic Antibody Testing in a Tertiary Hospital. J. Clin.
Pathol., 2009, 62(8), 743–745.
Availability of data [10] Houben, E.; Bax, WA.; van Dam, B.; Slieker, W.A.T.; Verhave, G.;
Frerichs, F.C.P.; van Eijk, I.C.; Boersma, W.G.; de Kuyper, G.T.M.;
Penne, E.L. Diagnosing ANCA-associated Vasculitis in ANCA
Data can be obtained from the corresponding author Positive Patients: A Retrospective Analysis on the Role of Clinical
following formal request. Symptoms and the ANCA Titre. Medicine (Baltimore), 2016,
95(40), e5096.
References [11] Arnold, D.; Timms, A.; Luqmani, R.; Misbah, S.A. Does a Gating
Policy for ANCA Overlook Patients with ANCA Associated
Vasculitis? An Audit of 263 Patients. J. Clin. Pathol., 2010, 63(8),
[1] Savige, J.; Gillis, D.; Benson, E.; Davies, D.; Esnault, V.; 678–680.
Falk, R.J.; Hagen, E.C.; Jayne, D.; Jennette, J.C.; Paspaliaris, B.; [12] Tsiveriotis, K.; Tsirogianni, A.; Pipi, E.; Soufleros, K.;
Pollock, W.; Pusey, C.; Savage, C.O.; Silvestrini, R.; van der Papasteriades, C. Antineutrophil Cytoplasmic Antibodies Testing
Woude, F.; Wieslander, J.; Wiik, A. International Consensus in a Large Cohort of Unselected Greek Patients. Autoimmune Dis.,
Statement on Testing and Reporting of Antineutrophil Cytoplasmic 2011, 2011, 626495.
Antibodies (ANCA). Am. J. Clin. Pathol., 1999, 111(4), 507–513. [13] Phatak, S.; Aggarwal, A.; Agarwal, V.; Lawrence, A.; Misra, R.
[2] Bossuyt, X.; Tervaert, J.W.C.; Arimura, Y.; Blockmans, D.; Flores- Antineutrophil Cytoplasmic Antibody (ANCA) Testing: Audit
Suárez, L.F.; Guillevin, L.; Hellmich, B.; Jayne, D.; Jennette, J.C.; from a Clinical Immunology Laboratory. Int. J. Rheum. Dis., 2017,
Kallenberg, C.G.M.; Moiseev, S.; Novikov, P.; Radice, A.; 20(6), 774–778.
Savige, J.A.; Sinico, R.A.; Specks, U.; van Paassen, P.; [14] Chehroudi, C.; Booth, R.A.; Milman, N. Diagnostic Outcome and
Zhao, M.H.; Rasmussen, N.; Damoiseaux, J.; Csernok, E. Position Indications for Testing in Patients with Positive ANCA at a Canadian
Paper: Revised 2017 International Consensus on Testing of ANCAs Tertiary Care Centre. Rheumatol. Int., 2018, 38(4), 641–647.
in Granulomatosis with Polyangiitis and Microscopic Polyangiitis.
Nat. Rev. Rheumatol., 2017, 13(11), 683–692. [15] Kamar, F.B.; Hawkins, T.L.A. Antineutrophil Cytoplasmic
[3] Mandla, L.A.; Solomon, D.H.; Smith, E.L.; Lew, R.A.; Katz, J.N.; Antibody Induction Due to Infection: A Patient with Infective
Shmerling, R.H. Using Antineutrophil Cytoplasmic Antibody Endocarditis and Chronic Hepatitis C. Can. J. Infect. Dis. Med.
Testing to Diagnose Vasculitis: Can Test-ordering Guidelines Microbiol., 2016, 2016, 3585860.
Improve Diagnostic Accuracy? Arch. Intern. Med., 2002, 162(13), [16] Koderisch, J.; Andrassy, K.; Rasmussen, N.; Hartmann, M.;
1509–1514. Tilgen, W. “False-positive” Anti-neutrophil Cytoplasmic
[4] Genga, E.; Oyoo, O.; Adebajo, A. Vasculitis in Africa. Curr. Antibodies in HIV Infection. Lancet, 1990, 335(8699), 1227–1228.
Rheumatol. Rep., 2018, 20(2), 4. [17] Iordache, L.; Bengoufa, D.; Taulera, O.; Rami, A.; Lascoux-Combe,
[5] Adebajo, A.O.; Charles, P.; Maini, R.N.; Hazleman, B.L. C.; Day, N.; Parrinello, M.; Sellier, P.O.; Molina, J.M.; Mahr, A.
Autoantibodies in Malaria, Tuberculosis and Hepatitis B in a West Nonorgan-specific Autoantibodies in HIV-infected Patients in the
African Population. Clin. Exp. Immunol., 1993, 92(1), 73–76. HAART Era. Medicine (Baltimore), 2017, 96(10), e6230.
[6] Moiseev, S. 2020 International Consensus on ANCA Testing [18] Savige, J.; Pollock, W.; Trevisin, M. What do Antineutrophil
Beyond Systemic Vasculitis. Autoimmun. Rev., 2020, 19, 102618. Cytoplasmic Antibodies (ANCA) Tell Us? Best Pract. Res. Clin.
[7] Damoiseaux, J.; Csernok, E.; Rasmussen, N.; Moosig, F.; Rheumatol., 2005, 19(2), 263–276.
van Paassen, P.; Baslund, B.; Vermeersch, P.; Blockmans, D.; [19] Chen, M.; Yu, F.; Wang, S.X.; Zou, W.Z.; Zhao, M.H.; Wang, H.Y.
Tervaert, J.W.C.; Bossuyt, X. Detection of Antineutrophil Antineutrophil Cytoplasmic Autoantibody-negative Pauci-immune
Cytoplasmic Antibodies (ANCAs): A Multicentre European Crescentic Glomerulonephritis. J. Am. Soc. Nephrol., 2007, 18(2),
Vasculitis Study Group (EUVAS) Evaluation of the Value of 599–605.

©2022 AccScience Publishing